Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Operating Margin (2016 - 2025)

Biomerica's Operating Margin history spans 16 years, with the latest figure at 113.47% for Q4 2025.

  • For Q4 2025, Operating Margin fell 5277.0% year-over-year to 113.47%; the TTM value through Nov 2025 reached 20.51%, down 1043.0%, while the annual FY2025 figure was 19.66%, 337.0% down from the prior year.
  • Operating Margin for Q4 2025 was 113.47% at Biomerica, down from 81.01% in the prior quarter.
  • Across five years, Operating Margin topped out at 616.15% in Q2 2025 and bottomed at 196.66% in Q1 2024.
  • The 5-year median for Operating Margin is 91.78% (2023), against an average of 30.29%.
  • The largest annual shift saw Operating Margin plummeted -14720bps in 2023 before it soared 71099bps in 2024.
  • A 5-year view of Operating Margin shows it stood at 24.31% in 2021, then crashed by -362bps to 112.42% in 2022, then increased by 9bps to 102.55% in 2023, then surged by 41bps to 60.7% in 2024, then tumbled by -87bps to 113.47% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Operating Margin are 113.47% (Q4 2025), 81.01% (Q3 2025), and 616.15% (Q2 2025).